Allison Dorval Voyager Therapeutics, Inc. (VYGR) insider trading activity

VYGR Quotes by TradingView

Allison Dorval is Chief Financial Officer of Voyager Therapeutics, Inc.. Currently has a direct ownership of 109,894 shares of VYGR, which is worth approximately $596,724. The most recent transaction as insider was on Mar 19, 2021, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
0% 3M change
0% 12M change
Total Value Held $596,724

Allison Dorval Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2021
BUY
Grant, award, or other acquisition
-
30,000 Added 21.44%
109,894 Common Stock
Feb 16 2021
BUY
Grant, award, or other acquisition
-
34,000 Added 29.85%
79,894 Common Stock
Feb 11 2021
SELL
Open market or private sale
$24,054 $7.55 p/Share
3,186 Reduced 6.49%
45,894 Common Stock
Jan 12 2021
SELL
Open market or private sale
$25,360 $8.62 p/Share
2,942 Reduced 5.66%
49,080 Common Stock

Also insider at

PBYI
PUMA BIOTECHNOLOGY, INC. Healthcare
Director
AVTE
Aerovate Therapeutics, Inc. Healthcare
VERV
Verve Therapeutics, Inc. Healthcare
Chief Financial Officer
AD

Allison Dorval

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VYGR